Middlesex Uses Robotic System to Perform Partial Knee Replacement Surgeries
MIDDLETOWN — Middlesex Hospital is now using robotics to perform partial knee replacement surgeries.
Dr. Robert Geist and Dr. Terry Reardon, orthopedic surgeons, recently performed the first robotic partial knee replacement surgeries at Middlesex using new technology called the NAVIO™ Surgical System. This system is manufactured by Smith & Nephew, a global medical technology business.
The NAVIO Surgical System does not require a pre-operative CT scan. Instead, surgeons collect patient-specific data during the procedure to build a 3D model of a patient’s knee. This information is used to plan a surgery. The system’s robotics-assisted handpiece is then used to prepare the bone and position cut guides based on the information that was collected. During the bone preparation process, the handpiece is continually tracked in real-time in relation to the intended surgical plan while its robotic-assistance allows the surgeon to remove only the bone required for the placement of the implant.
“This device allows us to reliably place the components with accuracy and precision and improve outcomes,” says Dr. Geist, who also serves as president of Middlesex’s medical staff.
Dr. Reardon says that it is the orthopedic surgeons who actually perform the procedure using the NAVIO robots. The robot assists with planning the removal of the arthritic bone to get the optimal placement of the new knee. The robot then assists with evaluating the function of the knee replacement during surgery to confirm the accurate placement of the components.
Together, Dr. Geist and Dr. Reardon have 60 years experience performing knee replacements at Middlesex Hospital.
It is important to note that not all patients are candidates for a surgery using the NAVIO Surgical System. It is important for patients to talk to their doctor to determine the best course of action.
For more information about Middlesex Hospital Orthopedics, visit www.middlesexhospital.org.
About Smith & Nephew
Smith & Nephew is a global medical technology business that is dedicated to helping health care professionals improve people’s lives. With leadership positions in orthopaedic reconstruction, advanced wound management, sports medicine and trauma and extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2017 were almost $4.8 billion. Smith & Nephew is a member of the FTSE100 (LSE-SN, NYSE:SNN).
For more information about Smith & Nephew, visit www.smith-nephew.com.
Contact Information
Public Relations Director
Amanda Falcone
860-358-6980
amanda.falcone@midhosp.org